HCA Healthcare, Inc. (HCA) — Analyst outlook / Analyst consensus target is. Based on 46 analyst ratings, the consensus is bullish — 30 Buy, 14 Hold, 2 Sell.
The consensus price target is $523.92 (low: $425.00, high: $635.00), representing an upside of 5.1% from the current price $498.66.
Analysts estimate Earnings Per Share (EPS) of $21.94 and revenue of $70.57B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $22.27 vs est $21.94 (beat +1.5%). 2025: actual $28.62 vs est $27.68 (beat +3.4%). Analyst accuracy: 98%.
HCA Stock — 12-Month Price Forecast
$523.92
▲ +5.07% Upside
Average Price Target
Based on 46 Wall Street analysts offering 12-month price targets for HCA Healthcare, Inc., the average price target is $523.92, with a high forecast of $635.00, and a low forecast of $425.00.
The average price target represents a +5.07% change from the last price of $498.66.
Highest Price Target
$635.00
Average Price Target
$523.92
Lowest Price Target
$425.00
HCA Analyst Ratings
Buy
Based on 46 analysts giving stock ratings to HCA Healthcare, Inc. in the past 3 months
EPS Estimates — HCA
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $22.27
vs Est $21.94
▲ 1.5% off
2025
Actual $28.62
vs Est $27.68
▲ 3.3% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving.
Revenue Estimates — HCA
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $70.603B
vs Est $70.566B
▲ 0.1% off
2025
Actual $75.600B
vs Est $75.735B
▼ 0.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
